Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dosing and Outcomes Study of Erythropoietic Stimulating Therapies

NCT00212862 is registered in ClinicalTrials.gov with Ortho Biotech Products, L.P. as lead sponsor.

NCT NCT00212862
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00212862 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dosing and Outcomes Study of Erythropoietic Stimulating Therapies
Lead sponsor
Ortho Biotech Products, L.P.
Phase
Observational
Overall status
Completed
Start date
December 31, 2003
Completion date
July 31, 2009
Enrollment
2,130 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, cancer